 CAMBRIDGE, Mass., Dec. 4, 2020 PRNewswire -- Cogent Biosciences, Inc. Cogent NASDAQ: COGT, a biotechnology company focused on developing precision therapies for genetically defined diseases, today announced the closing of its upsized underwritten public offering of 11,794,872... 